The RTW Foundation is proud to support pioneers who are breaking new ground in the fight against diseases that may not represent compelling commercial opportunities, but do result in significant human suffering.
The Foundation is able to provide capital, manpower, and logistical support to help scientists push such projects forward. In addition, the Foundation aims to assist in advocacy and resource coordination for patients and their families.
INVESTING IN HUMAN LIVES
Since 2009, RTW Investments has identified and invested in some of the most exciting new areas of medicine. We were early backers of both gene therapy and oligos, whose trailblazers have produced breakthroughs that are transforming patients’ lives. We continue to invest in companies that address unmet needs, including various cancers, neurodegenerative disorders, autoimmune diseases, viral infections, and numerous rare diseases.
The RTW Foundation represents an extension of that mission. Our research process helps us to focus our efforts and allocate resources toward those projects that have the greatest potential to benefit humanity. To our recipients, we provide not only financial backing, but also guidance gleaned from our experience in drug development and company building.
The Foundation aims to foster the development of medicines that fall into either or both of these categories:
Early stage therapeutic technologies that our research team finds promising.
Designed to treat diseases with high unmet need and limited commercial potential.
VALUING WHAT MATTERS
The RTW Foundation is specifically directed to prioritize benefits to patients over financial reward.
Our dedicated staff know that only part of the struggle to relieve patients’ suffering takes place in laboratories. Many of the diseases we target affect not only patients but their families as well, often in devastating ways. We aid these families by
Providing information and coordinating assistance
Advocating for patients whose voices might not otherwise be heard
Raising public awareness
We believe biotech will be a key value creator over the next decade.
Contact us to learn more about RTW’s expertise, insight and experience in identifying and working with companies focused in areas of breakthrough innovation.